biotech · Chronic Peripheral Neuropathy Pain in Diabetics · Diabetic Peripheral Neuropathy · XTLB
XTL BIOPHARMACEUTICALS
XTL BIOPHARMACEUTICALS LTD
XTL Biopharmaceuticals is a biotech organization headquartered in Raanana, USA. It trades on NYSE under ticker XTLB. Primary therapeutic focus areas include Chronic Peripheral Neuropathy Pain in Diabetics, Diabetic Perip
Raanana, USA HQ
1993 Founded
3 Employees
Public company Type
XTLB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Raanana, USA
- Founded
- 1993
- Employees
- 3
- Programs
- 4
- Drugs
- 1
- Patents
- 7
Bicifadine
Phase 2 · small molecule · Diabetic Peripheral Neuropathy
Bicifadine for Diabetic Peripheral Neuropathy is a Phase 2 program (small_molecule) at XTL BIOPHARMACEUTICALS LTD with 1 ClinicalTrials.gov record(s).
Internal code XTL B07-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XTL BIOPHARMACEUTICALS LTD
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Diabetic Peripheral Neuropathy
- Status
- active
- Trials
- 1